Skip to content

Source filing unavailable

Q3 2021 · —
Revenue—
Net Income-$16.41Mno prior Q3 2020 on fileN/M vs Q2 2021
EPS Diluted-$1.52no prior Q3 2020 on fileno prior Q2 2021 on file
Operating Income-$10,427,000—

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

no prior Q3 2020 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Prime Medicine, Inc. · CIK 1894562 · Engraved from SEC EDGAR